decisionhealth Newsletters, Part B News - 2015 Issue 6 (June)
Proposed prescription payment formula creates winners and losers
Subscribe or sign in to view the full article.
Article Overview
This article reviews a Medicare Payment Advisory Commission proposal affecting reimbursement for drugs administered in the office setting. It is aimed at clinicians, practice managers, and billing professionals who track Medicare payment policy and drug reimbursement trends. The discussion focuses on the proposed shift from the current payment methodology to a flat-fee add-on approach, along with the expected distributional effects on different drug price tiers.
Why This Topic Matters
Office-based drug reimbursement can affect prescribing patterns, practice revenue, and Medicare spending. Understanding this policy proposal helps readers assess how a change in payment methodology could alter reimbursement across drug price ranges.
What You Will Learn
- What Medicare’s advisory commission proposed for office-administered drug payment
- How the article frames the expected effect on lower-priced versus higher-priced drugs
- Why the proposal is relevant to Medicare reimbursement policy and practice economics
- Which types of providers and billing stakeholders may be affected by the change
Who Should Read This
- Physicians who administer drugs in office settings
- Medical practice managers
- Medical coders and billers
- Revenue cycle staff
- Healthcare policy analysts
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com